| Name | Title | Contact Details |
|---|
Karl Storz industrial products are manufactured to the highest world standards and supported by a highly trained Customer Service team.
Decade of Discovery is a major research initiative led by the Minnesota Partnership for Biotechnology and Medical Genomics focused on preventing, optimally treating and ultimately curing diabetes.
Wheel is the health tech company putting great care within everyone`s reach. We provide everything companies and clinicians need to serve patients virtually, including a complete virtual care platform and nationwide clinician network. Our offering makes it easy for companies to build virtual care services and for clinicians to manage their practice in one place — including onboarding, support, and the ability to work across several highly-vetted opportunities. Imagine a future without waiting rooms, where patients are quickly seen by the best clinician for their care need, who is happily working on their own schedule and on their own terms. That`s just a glimpse of the future we`re building—where everyone has access to equitable, high-quality care. Having already raised over $200 million in funding through top investors, including Lightspeed Venture Partners, Tiger Global, Coatue, and Salesforce Ventures, Wheel is, well, on a roll. We`re powering the most innovative companies in healthcare and racking up accolades like being named to Forbes` Next Billion-Dollar Startups and Built In`s Best Remote-First Places to Work. But our work is far from over. Embracing the full potential of virtual care is a challenging transition for a complex industry. We`re looking for bright, driven minds to help us solve problems and explore new possibilities for our platform. Become a Wheelie and use your skills to positively impact the health of millions. You`ll work alongside some of the most thoughtful go-getters in tech, at a company where care isn`t just our business, it`s our ethos. We value empathy, trust, and collaboration, with a healthy dose of tenacity and speed. Check out our careers page for our latest openings and join us in putting great care within everyone`s reach.
Medefield is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Cellanyx has developed proprietary live tumor cell phenotypic biomarker tests to improve cancer risk-stratification and allow informed clinical decision making. The Companys unique approach provides quantitative and actionable information based on analysis of thousands of live tumor cells. The Companys tests employ a microfluidic platform combined with machine vision and machine learning approaches to analyze phenotypic morphological, biochemical and biophysical markers. Cellanyx has demonstrated initial clinical proof-of-concept with its lead phenotypic test in prostate cancer. The initial clinical proof-of-concept study was conducted to demonstrate improved risk stratification in men with low and intermediate Gleason grade (6 and 7) disease and reduce the number of repeat biopsies. Furthermore, analysis of field samples (away from the suspicious core) demonstrated the potential value of Cellanyx phenotypic test as it was able to analyze the tumor microenvironment conditions and predict expected adverse pathology from samples that were not taken from the suspicious core. These new findings from the Cellanyx prostate test are transformative as it will reduce the errors in diagnosing cancers early due to sampling heterogeneity of prostate biopsies.